LEXICON PHARMACEUTICALS, INC. - 10-Q Filing
Lexicon Pharmaceuticals reports Q3 2026 financial results including updates on Novo Nordisk development milestones and Hercules Capital loan facility tranches.
Tickers: $LXRX
More Regulatory news
- Boost Run Inc. - 8-K Filing
- INTERFACE INC - 8-K Filing
- Neonode Inc. - 10-Q Filing
- Virtuix Holdings Inc. - 8-K Filing
- Neonode Inc. - 8-K Filing
- Beyond Air, Inc. - 10-Q Filing
- Carter Bankshares, Inc. - 8-K Filing
- Marvell Technology, Inc. - 8-K Filing
- VISHAY INTERTECHNOLOGY INC - 8-K Filing
- LATTICE SEMICONDUCTOR CORP - 4 Filing